Free Trial
→ $2 Trillion Disappears Because of Fed's Secretive New Move (From Stansberry Research) (Ad) Buy VOR Stock  Free VOR Stock Alerts

Vor Biopharma (VOR) SEC Filings & 10K Form

Vor Biopharma logo
$0.85 -0.04 (-4.19%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 +0.04 (+5.04%)
As of 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Vor Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
03/20/2025
3:45 PM		Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/20/2025
3:48 PM		Vor Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:01 PM		Vor Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
3:29 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM		FMR LLC (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:35 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:36 PM		ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
3:37 PM		Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
8:19 PM		Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:20 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:22 PM		Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
8:23 PM		ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
11:15 PM		Vor Biopharma (Filer)
Form EFFECT
01/29/2025
4:24 PM		Vor Biopharma (Filer)
Form 424B3
01/21/2025
3:24 PM		Vor Biopharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2025
5:39 PM		Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:41 PM		Kalir Erez (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
8:06 AM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:53 PM		Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13D
01/02/2025
6:37 PM		Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
6:42 PM		Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:15 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
5:51 PM		RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
Form SCHEDULE 13D/A
12/30/2024
5:52 PM		Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:17 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2024
8:05 AM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
6:39 AM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:33 PM		Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
Form SC 13G/A
11/08/2024
3:15 PM		ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:15 PM		Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:20 PM		Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM		ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM		Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:15 PM		Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
3:16 PM		Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
3:17 PM		Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:05 AM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:06 PM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Do this Before Elon's Reveal on April 23rd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
08/30/2024
3:01 PM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:29 PM		Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:30 PM		ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
4:04 PM		Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:22 PM		Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2024
5:09 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:38 PM		Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
3:54 PM		Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:10 PM		Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM		Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM		Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM		Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:40 PM		Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:39 PM		Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
3:05 PM		Vor Biopharma (Filer)
Form DEF 14A
04/09/2024
3:07 PM		Vor Biopharma (Filer)
Form DEFA14A
04/09/2024
3:10 PM		Vor Biopharma (Filer)
Form ARS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:VOR) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored